Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Anthony Hunt is active.

Publication


Featured researches published by Thomas Anthony Hunt.


Bioorganic & Medicinal Chemistry Letters | 2012

Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.

Thomas Anthony Hunt; Hazel C. Atherton-Watson; Jake Axford; Stephen Paul Collingwood; Kevin Coote; Brian Cox; Sarah Czarnecki; Henry Danahay; Nicholas James Devereux; Catherine Howsham; Peter Hunt; Victoria Paddock; Derek Paisley; Alice Young

We report the identification of a novel series of human epithelial sodium channel (ENaC) blockers that are structurally distinct from the pyrazinoyl guanidine chemotype found in prototypical ENaC blockers such as amiloride. Following a rational design hypothesis a series of quaternary amines were prepared and evaluated for their ability to block ion transport via ENaC in human bronchial epithelial cells (HBECs). Compound 11 has an IC(50) of 200nM and is efficacious in the Guinea-pig tracheal potential difference (TPD) model of ENaC blockade with an ED(50) of 44μgkg(-1) at 1h. As such, pyrazinoyl quaternary amines represent the first examples of a promising new class of human ENaC blockers.


Archive | 2008

Bicyclic heteroaryl compounds and their use as kinase inhibitors

Ian Bruce; James Dale; Thomas Anthony Hunt


Archive | 2009

3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases

Stephen Paul Collingwood; Catherine Howsham; Thomas Anthony Hunt


Archive | 2012

Compositions and methods for modulating lpa receptors

John Tellew; Xia Wang; Yongqin Wan; Yun Feng Xie; Shifeng Pan; Jiqing Jiang; Yongping Xie; Thomas Anthony Hunt; Lee Edwards; David Beattie; Mark Patrick Healy; Ryan West; Andrew Stuart Lister


Pharmaceutical patent analyst | 2015

ENaC Inhibitors for the Treatment of Cystic Fibrosis

Rebecca Butler; Thomas Anthony Hunt; Nichola Smith


Archive | 2008

Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel

Gurdip Bhalay; Emma Budd; Graham Charles Bloomfield; Stephen Paul Collingwood; Andrew Dunstan; Lee Edwards; Peter Gedeck; Catherine Howsham; Peter Hunt; Thomas Anthony Hunt; Paul Oakley; Nichola Smith


Archive | 2014

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

Gurdip Bhalay; Emma Budd; Graham Charles Bloomfield; Stephen Paul Collingwood; Andrew Dunstan; Lee Edwards; Peter Gedeck; Catherine Howsham; Peter Hunt; Thomas Anthony Hunt; Paul Oakley; Nichola Smith


Archive | 2009

Preparation of cyclic guanidinocarbonylpyrazines as epithelial sodium channel (ENaC) blockers

Gurdip Bhalay; Emma Budd; Graham Charles Bloomfield; Stephen Paul Collingwood; Andrew Dunstan; Lee Edwards; Peter Gedeck; Catherine Howsham; Peter Hunt; Thomas Anthony Hunt


Archive | 2008

Spirocyclic amiloride analogues as ENac blockers

Gurdip Bhalay; Emma Budd; Graham Charles Bloomfield; Stephen Paul Collingwood; Andrew Dunstan; Lee Edwards; Peter Gedeck; Catherine Howsham; Peter Hunt; Thomas Anthony Hunt; Paul Oakley; Nichola Smith


Archive | 2008

Spirocyclic analogs amiloride as blocking ENaC

Gurdip Bhalay; Emma Budd; Graham Charles Bloomfield; Stephen Paul Collingwood; Andrew Dunstan; Lee Edwards; Peter Gedeck; Catherine Howsham; Peter Hunt; Thomas Anthony Hunt; Paul Oakley; Nichola Smith

Collaboration


Dive into the Thomas Anthony Hunt's collaboration.

Researchain Logo
Decentralizing Knowledge